AnaptysBio Inc

ANABV NASDAQ Healthcare & Biotech United States
43.80 $

Biotechnology company developing therapeutic antibodies to treat inflammatory and immunological diseases.

Performance & Momentum

6 Months 3.78 %
1 Year 3.78 %
3 Years 3.78 %
5 Years 6.55 %

Similar stocks to AnaptysBio Inc

Anantys Community

Be the first to share your analysis on AnaptysBio Inc.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases